- Home
- ADVB vs CRIS Comparison
ADVB vs CRIS Comparison
Compare ADVB & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADVB
- CRIS
- Stock Information
- Founded
- ADVB 2014
- CRIS 2000
- Country
- ADVB United States
- CRIS United States
- Employees
- ADVB N/A
- CRIS N/A
- Industry
- ADVB Medical Specialities
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ADVB Health Care
- CRIS Health Care
- Exchange
- ADVB Nasdaq
- CRIS Nasdaq
- Market Cap
- ADVB 20.8M
- CRIS 21.3M
- IPO Year
- ADVB 2025
- CRIS 2000
- Fundamental
- Price
- ADVB $0.69
- CRIS $2.16
- Analyst Decision
- ADVB
- CRIS Strong Buy
- Analyst Count
- ADVB 0
- CRIS 2
- Target Price
- ADVB N/A
- CRIS $16.50
- AVG Volume (30 Days)
- ADVB 57.0K
- CRIS 77.4K
- Earning Date
- ADVB 08-03-2025
- CRIS 07-31-2025
- Dividend Yield
- ADVB N/A
- CRIS N/A
- EPS Growth
- ADVB N/A
- CRIS N/A
- EPS
- ADVB N/A
- CRIS N/A
- Revenue
- ADVB N/A
- CRIS $11,202,000.00
- Revenue This Year
- ADVB N/A
- CRIS N/A
- Revenue Next Year
- ADVB N/A
- CRIS $10.67
- P/E Ratio
- ADVB N/A
- CRIS N/A
- Revenue Growth
- ADVB N/A
- CRIS 14.17
- 52 Week Low
- ADVB $0.69
- CRIS $1.02
- 52 Week High
- ADVB $4.10
- CRIS $8.42
- Technical
- Relative Strength Index (RSI)
- ADVB N/A
- CRIS 45.09
- Support Level
- ADVB N/A
- CRIS $2.40
- Resistance Level
- ADVB N/A
- CRIS $2.57
- Average True Range (ATR)
- ADVB 0.00
- CRIS 0.23
- MACD
- ADVB 0.00
- CRIS -0.04
- Stochastic Oscillator
- ADVB 0.00
- CRIS 0.00
About ADVB Advanced Biomed Inc. Common Stock
Advanced Biomed Inc operates through its subsidiaries that are responsible for the main operation and the design and development of the company's primary technologies and products. It has been focusing on the integration of multiple interdisciplinary technologies and established its microfluidic technology platform. Utilizing the physical and molecular biological characteristics of tumor cells, the company has developed various advanced and original research through the joint application of semiconductor technology and biotechnology. devices, A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.